Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 47 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10363248

    Salts of heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  2. US 10363246

    Methods and compositions for treatment of epileptic disorders

    OVID THERAPEUTICS INC. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  3. US 10363261

    Enolase inhibitors and methods of treatment therewith

    The Board of Regents of the University of Texas System · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  4. US 10363247

    (S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer

    Karyopharm Therapeutics Inc. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  5. US 10357539

    Use of peptides that block metadherin-SND1 interaction as treatment for cancer

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  6. US 10357453

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    O.D. Ocular Discovery Ltd. · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  7. US 10350273

    Treatment of hormonal disorders of growth

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  8. US 10350228

    Treatment of sickle cell disease and inflammatory conditions

    Regents of the University of Minnesota · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  9. US 10350256

    Compositions for the treatment of dermatological conditions, disorders or diseases

    Veit Hoermann Gesellschaft Für Unternehmenskommunikation mbH · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  10. US 10351589

    3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders

    Umecrine Cognition AB · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  11. US 10350183

    Intravenous baclofen formulations and treatment methods

    Regents of the University of Minnesota · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  12. US 10342815

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  13. US 10342786

    P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

    Fulcrum Therapeutics, Inc. · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  14. US 10342804

    Steroid compound for use in the treatment of hepatic encephalopathy

    Umecrine Cognition AB · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  15. US 10335466

    AADC polynucleotides for the treatment of parkinson's disease

    VOYAGER THERAPEUTICS, INC. · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  16. US 10327853

    System and method of performing treatment along a lumen network

    Covidien LP · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  17. US 10330685

    Markers for sepsis treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  18. US 10322113

    Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  19. US 10322129

    Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same

    O.D. Ocular Discovery Ltd. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  20. US 10322124

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  21. US 10314850

    Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  22. US 10314885

    Oxytocin treatment to modify blood glucose and treat metabolic disease

    The Regents of the University of California · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  23. US 10307469

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  24. US 10307418

    Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds

    Platform Brightworks Two, Ltd. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.